SEC Form 4 · accession 0001549923-16-000001
IMPLANT SCIENCES CORP · IMSC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Darryl Jones
Officer — EVP, Sales & Marketing
Period of report
Aug 14, 2015
Accepted (ET)
Feb 19, 2016 · 2:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001068874
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.78 | Aug 14, 2015 | A | 1,002,088 | A | — | Aug 14, 2025 | Common Stock | 1,002,088 | 1,002,088 | D |
Explanation of responses
- F1Exercisable in three equal annual installments commencing on August 14, 2016.